Astal Laboratories (BOM:512600) EPS (Basic): ₹7.00 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512600 Astal Laboratories Ltd BOM:512600
48 GF Score
Price ₹82.55
GF Value ₹52.99
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Astal Laboratories EPS (Basic)?

Astal Laboratories BOM:512600 +2.62% 48 EPS (Basic) is ₹7.00 as of Mar. 2026. GuruFocus rates BOM:512600 with a GF Score™ of 48/100 and a GF Value™ of ₹52.99 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Astal Laboratories's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹0.29. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.00.

Astal Laboratories's EPS (Diluted) for the three months ended in Mar. 2026 was ₹0.28. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.72.

Astal Laboratories's EPS without NRI for the three months ended in Mar. 2026 was ₹0.28. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 5.72.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Astal Laboratories  (BOM:512600) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Astal Laboratories EPS (Basic) Related Terms

Astal Laboratories EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Astal Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astal Laboratories EPS (Basic) Chart

Astal Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 0.04 1.55 9.08 4.76

Astal Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 2.13 2.40 2.19 0.29
BOM:512600
48GF Score
Astal Laboratories Ltd BOM:512600
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astal Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Astal Laboratories's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(81.155-0)/42.216
=1.92

Astal Laboratories's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10.859-0)/37.705
=0.29

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹7.00 mean?
Astal Laboratories (BOM:512600) has a EPS (Basic) of ₹7.00 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Astal Laboratories and its competitors.
Is Astal Laboratories' EPS (Basic) too high?
Astal Laboratories' current EPS (Basic) is ₹7.00. Overall, Astal Laboratories has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Astal Laboratories' EPS (Basic) compare to ZTS and UTHR?
Astal Laboratories' EPS (Basic) of ₹7.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Astal Laboratories and its competitors. Astal Laboratories's current EPS (Basic) is ₹7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astal Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Astal Laboratories (BOM:512600) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹52.99, compared to a current price of ₹82.55 — trading 55.8% above its estimated fair value. The current EPS (Basic) is ₹7.00. Astal Laboratories' overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Astal Laboratories (BOM:512600), the current EPS (Basic) is ₹7.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astal Laboratories (BOM:512600) Overvalued in 2026?

Based on GuruFocus' analysis, Astal Laboratories stock appears to be overvalued. The current stock price of ₹82.55 is trading 55.8% above its estimated GF Value™ of ₹52.99. GuruFocus considers Astal Laboratories to be Significantly Overvalued.

Key valuation signals for BOM:512600:

  • EPS (Basic): ₹7.00
  • GF Value™: ₹52.99 vs. price of ₹82.55 (55.8% above fair value)
  • GF Score™: 48/100 with 8 warning signs

No single metric tells the full story. See the BOM:512600 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astal Laboratories Business Description

Address D-1, Motilal Atal Road, Behind Hotel Neelam, Jaipur, RJ, IND, 302001
Astal Laboratories Ltd is an India-based company. The main objects of the company are to manufacture and sales of Pharmaceutical Intermediates and Bulk Drugs. The company has a single segment, i.e., Pharmaceuticals.
48GF Score

Get the complete analysis for BOM:512600

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹82.55
Price
₹52.99
GF Value